Skip to main content

Table 2 Virologic, Biochemical Variables of Patients at 24 Weeks' Treatment

From: Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial

Variable CIFN group (n = 71) IFN-alpha group (n = 68)
ALT normalization, n (%) 38 (53.5) 41 (60.3)
Loss of HBV-DNA, n (%) 18 (25.4) 14 (20.6)
HBeAg/anti-HBe seroconversion, n (%) 10 (14.1) 15 (22.1)
Loss of HbeAg, n (%) 10 (14.1) 7 (10.3)
Complete response, n (%) 5 (7.0) 5 (7.4)
Partial response, n (%) 25 (35.2) 23 (33.8)
  1. CIFN, consensus interferon; IFN, interferon